James Nokes/BMC Med
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.Koltai, M.
Moyes, J.
Nyawanda, B.
Nyiro, J.
Munywoki, P. K.
Tempia, S.
Li, X.
Antillon, M.
Bilcke, J.
Flasche, S.
Beutels, P.
Nokes, D. J.
Cohen, C.
Jit, M.
BMC Med, (2023). 21:120
Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.Nyawanda, B. O.
Murunga, N.
Otieno, N. A.
Bigogo, G.
Nyiro, J. U.
Vodicka, E.
Bulterys, M.
Nokes, D. J.
Munywoki, P. K.
Emukule, G. O.
BMC Med, (2023). 21:122
The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.Mburu, C. N.
Ojal, J.
Chebet, R.
Akech, D.
Karia, B.
Tuju, J.
Sigilai, A.
Abbas, K.
Jit, M.
Funk, S.
Smits, G.
van Gageldonk, P. G. M.
van der Klis, F. R. M.
Tabu, C.
Nokes, D. J.
Lshtm Cmmid Covid- Working Group
Scott, J.
Flasche, S.
Adetifa, I.
BMC Med, (2021). 19:35
Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya.Flasche, S.
Ojal, J.
Le Polain de Waroux, O.
Otiende, M.
O'Brien, K. L.
Kiti, M.
Nokes, D. J.
Edmunds, W. J.
Scott, J. A. G.
BMC Med, (2017). 15:113
